MMizuho OOracle · ORCL

Mizuho Reiterates Outperform on Oracle, $320 PT

Jul 21, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$320
Previous
Implied upside
+164%

Mizuho analyst Siti Panigrahi reiterated an Outperform rating and $320 price target on Oracle (NYSE: ORCL).

“We believe ORCL shares, trading at multi-year lows, reflects one of the most attractive risk/reward profiles in our coverage.

Shares trade at 14x CY27 non-GAAP EPS, a discount to every comparable infrastructure peer despite above-peer growth, even as execution strengthens across capacity conversion, RPO quality, and financing visibility.

Management delivered two consecutive strong quarters while providing increasing clarity/disclosure on funding amount, timing, and sources; rising BYOH/prepaid adoption, confirming flat-to-better gross margin with materially higher ROIC; CapEx; and capacity coming online in F1Q27 (1GW) versus all of FY26 (~1.2GW).

We see several catalysts ahead, including continued capacity monetization through FY27 and FY28, a fading financing overhang as the ATM executes, and early Applications reacceleration.

Visibility is also building toward the FY29/FY30 FCF inflection, which we expect to support a rerate well before that point arrives.

We reiterate Outperform, with shares trading at 6x its FY30 non-GAAP EPS target of $21.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.